| Literature DB >> 27807398 |
Federico G Seifarth1, Neilendu Kundu2, Alfredo D Guerron3, Mary M Garland4, Michaela W G Gaffley4, Sarah Worley5, Colin G Knight6.
Abstract
BACKGROUND AND OBJECTIVES: Transumbilical laparoscopic-assisted appendectomy (TULAA) carries a high risk for surgical site infection. We investigated the effect of a bio-occlusive umbilical vacuum dressing on wound infection rates after TULAA for patients with acute appendicitis and compared to it with a conventional 3-port appendectomy with a nonvacuum dressing.Entities:
Keywords: Appendectomy; Appendicitis; TULAA; Vacuum dressing; Wound Infection
Mesh:
Year: 2016 PMID: 27807398 PMCID: PMC5081401 DOI: 10.4293/JSLS.2016.00070
Source DB: PubMed Journal: JSLS ISSN: 1086-8089 Impact factor: 2.172
Subcohort Characteristics of All Patients With Acute Appendicitis
| Factor | Total (N = 1283) |
|---|---|
| Sex, n (%) | |
| Male | 765 (60) |
| Female | 518 (40) |
| Age (y), median [Q1, Q3] | 12 [9, 15] |
| Age <5 y, n (%) | 36 (3) |
| Diagnosis, n (%) | |
| Acute appendicitis | 1283 (100) |
| Procedure, n (%) | |
| TULAA | 712 (55) |
| TPLA with Endocatch | 305 (24) |
| TPLA without Endocatch | 266 (21) |
| Extra/intracorporeal amputation, n (%) | |
| Intracorporeal amputation | 571 (45) |
| Extracorporeal amputation | 712 (55) |
| Access, n (%) | |
| Periumbilical | 515 (40) |
| Transumbilical | 768 (60) |
| Dressing, n (%) | |
| UVD with gauze no bacitracin | 276 (22) |
| UVD with cotton/gauze + bacitracin | 395 (31) |
| Occlusive dressing with gauze no bacitracin, no vacuum | 97 (8) |
| Dermabond | 107 (8) |
| Steri-Strips | 408 (32) |
| Technique/dressing group, n (%) | |
| 1. TPLA, periumbilical, intracorporeal, Dermabond® dressing | 107 (8) |
| 2. TPLA, periumbilical, intracorporeal, Steri-StripTM dressing | 408 (32) |
| 3. TPLA, transumbilical, intracorporeal, UVD with gauze without Bacitracin | 56 (4) |
| 4. TULAA, transumbilical, extracorporeal, occlusive umbilical dressing with gauze without vacuum | 97 (8) |
| 5. TULAA, transumbilical, extracorporeal, UVD with absorbent cotton/gauze and Bacitracin | 395 (31) |
| 6. TULAA, transumbilical, extracorporeal, UVD with gauze without Bacitracin | 220 (17) |
| Wound infection (Y/N), n (%) | 34 (3) |
Patients Undergoing TULAA (Groups 4–6)
| Factor | Total | Group 4 | Group 5 | Group 6 |
|---|---|---|---|---|
| TULAA | TULAA | TULAA | ||
| Occlusive Umbilical Dressing With Gauze Without Vacuum | UVD With Absorbent Cotton/Gauze and Bacitracin | UVD with Gauze Without Bacitracin | ||
| (n = 712) | (n = 97) | (n = 395) | (n = 220) | |
| Sex, n (%) | ||||
| Male | 427 (60) | 57 (59) | 235 (59) | 135 (61) |
| Female | 285 (40) | 40 (41) | 160 (41) | 85 (39) |
| Age (y), median [Q1, Q3] | 11 [8, 15] | 11 [8, 14] | 11 [9, 14] | 12 [9, 15] |
| Age <5 y, n (%) | 21 (3) | 5 (5) | 12 (3) | 5 (2) |
| Wound infection (Y/N), n (%) 95% CI | 27 (3.7) | 4 (4.1) (1.3%, 10.5%) | 17 (4.3) (2.7%, 6.8%) | 6 (2.7) (1.1%, 6.0%) |
Pairwise comparisons of groups on wound infections rate were performed using the Bonferroni correction to the significance level.
Significantly different from Group 2.